Last two sessions in the UK volume is increasing, something is brewing again in BIL ukhttp://bigcharts.marketwatch.com/javachart/javachart.asp?symb=au%3Abil&time=&freq=
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market